Smeenk, R., Van Velthuysen, M., Verwaal, V., et al. (2008). Appendiceal neoplasms and pseudomyxoma peritonei: A population based study. European Journal of Surgical Oncology (EJSO), 34(2), 196–201.

Article  CAS  Google Scholar 

Carr, N. J., Bibeau, F., Bradley, R. F., et al. (2017). The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei. Histopathology, 71(6), 847–858.

Article  Google Scholar 

Carr, N. J., Cecil, T. D., Mohamed, F., et al. (2016). A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: The results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi Process. The American journal of surgical pathology, 40(1), 14–26.

Article  Google Scholar 

Alakus, H., Babicky, M., Ghosh, P., et al. (2014). Genome-wide mutational analysis reveals core signaling pathways in mucinous neoplasms of the appendix. Cancer Research, 74(19), 1.

Google Scholar 

Sugarbaker, P. H. (1994). Pseudomyxoma peritonei: A cancer whose biology is characterized by a redistribution phenomenon. Annals of Surgery, 219(2), 109–111.

Article  CAS  Google Scholar 

Bree, E. D., Witkamp, A., Van De Vijver, M., et al. (2000). Unusual origins of pseudomyxoma peritonei. Journal of surgical oncology, 75(4), 270–274.

Article  Google Scholar 

Ronnett, B. M., Kurman, R. J., Zahn, C. M., et al. (1995). Pseudomyxoma peritonei in women: A clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Human Pathology, 26(5), 509–524.

Article  CAS  Google Scholar 

Young, R. H., Gilks, C. B., & Scully, R. E. (1991). Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. The American journal of surgical pathology, 15(5), 415–429.

Article  CAS  Google Scholar 

Misdraji, J., Yantiss, R. K., Graeme-Cook, F. M., et al. (2003). Appendiceal mucinous neoplasms: A clinicopathologic analysis of 107 cases. Am J Surg Pathol, 27(8), 1089–1103.

Article  Google Scholar 

Bradley, R. F., Stewart IV, J. H., Russell, G. B., et al. (2006). Pseudomyxoma peritonei of appendiceal origin: A clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. The American journal of surgical pathology, 30(5), 551–559.

Article  Google Scholar 

Sugarbaker, P. H. (2006). New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? The lancet oncology, 7(1), 69–76.

Article  Google Scholar 

Sugarbaker, P. H. (2001). Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Tumori Journal, 87(4), 3–5.

Article  Google Scholar 

Kusamura, S., O’Dwyer, S. T., Baratti, D., et al. (2008). Technical aspects of cytoreductive surgery. Journal of surgical oncology, 98(4), 232–236.

Article  Google Scholar 

Chua, T. C., Moran, B. J., Sugarbaker, P. H., et al. (2012). Early-and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Journal of Clinical Oncology, 30(20), 2449–2456.

Article  Google Scholar 

Gusani, N. J., Cho, S. W., Colovos, C., et al. (2008). Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Annals of Surgical Oncology, 15(3), 754–763.

Article  Google Scholar 

Miner, T. J., Shia, J., Jaques, D. P., et al. (2005). Long-term survival following treatment of pseudomyxoma peritonei: An analysis of surgical therapy. Annals of Surgery, 241(2), 300.

Article  Google Scholar 

Sommariva, A., Tonello, M., Rigotto, G., et al. (2021). Novel perspectives in pseudomyxoma peritonei treatment. Cancers (Basel), 13(23), 5965.

Govaerts, K., Lurvink, R. J., De Hingh, I. H. J. T., et al. (2021). Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. European Journal of Surgical Oncology, 47(1), 11–35.

Article  CAS  Google Scholar 

Kusamura, S., Barretta, F., Yonemura, Y., et al. (2021). The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery. JAMA Surg, 156(3), e206363.

Article  Google Scholar 

Järvinen, P., Ristimäki, A., Kantonen, J., et al. (2013). Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin. Scandinavian Journal of Surgery, 102(3), 145–151.

Article  Google Scholar 

Baratti, D., Kusamura, S., Nonaka, D., et al. (2009). Pseudomyxoma peritonei biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Annals of Surgery, 249(2), 243–249.

Article  Google Scholar 

Muzny, D. M., Bainbridge, M. N., Chang, K., et al. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330–337.

Article  CAS  Google Scholar 

Shukla, H. D. (2017). Comprehensive analysis of cancer-proteogenome to identify biomarkers for the early diagnosis and prognosis of cancer. Proteomes, 5(4), 28.

Article  CAS  Google Scholar 

Tan, A. C., & Tan, D. S. W. (2022). Targeted therapies for lung cancer patients with oncogenic driver molecular alterations. J Clin Oncol, 40(6), 611–625.

Article  CAS  Google Scholar 

Lau, K. H., Tan, A. M., & Shi, Y. (2022). New and emerging targeted therapies for advanced breast cancer. International Journal of Molecular Sciences, 23(4), 2288.

Noguchi, R., Yano, H., Gohda, Y., et al. (2015). Molecular profiles of high-grade and low-grade pseudomyxoma peritonei. Cancer Med, 4(12), 1809–1816.

Article  CAS  Google Scholar 

Stein, A., Strong, E., Clark Gamblin, T., et al. (2020). Molecular and genetic markers in appendiceal mucinous tumors: A systematic review. Annals of Surgical Oncology, 27(1), 85–97.

Article  Google Scholar 

Moher, D., Liberati, A., Tetzlaff, J., et al. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine, 6(7), e1000097.

Article  Google Scholar 

Sterne, J. A., Hernán, M. A., Reeves, B. C., et al. (2016). ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ, 355, i4919.

Article  Google Scholar 

Flatmark, K., Torgunrud, A., Fleten, K. G., et al. (2021). Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei. Journal for immunotherapy of cancer, 9(10), e003109.

Article  Google Scholar 

Moaven, O., Su, J., Jin, G., et al. (2020). Clinical implications of genetic signatures in appendiceal cancer patients with incomplete cytoreduction/HIPEC. Annals of Surgical Oncology, 27(13), 5016–5023.

Article  Google Scholar 

Liao, X., Vavinskaya, V., Sun, K., et al. (2020). Mutation profile of high-grade appendiceal mucinous neoplasm. Histopathology, 76(3), 461–469.

Article  Google Scholar 

King, M. C., Munoz-Zuluaga, C., Ledakis, P., et al. (2020). Germline and somatic genetic alterations in two first-degree relatives with appendiceal low-grade mucinous carcinoma peritonei. Clin Case Rep, 8(12), 3168–3177.

Article  Google Scholar 

Yanai, Y., Saito, T., Hayashi, T., et al. (2020). Molecular and clinicopathological features of appendiceal mucinous neoplasms. Virchows Archiv, 478(3), 413–426.

Foster, J. M., Patel, A., Zhang, C., et al. (2020). Investigating the utility of extended mutation analysis in gastrointestinal peritoneal metastasis. Journal of Surgical Oncology, 122(6), 1106–1113.

Lung, M. S., Mitchell, C. A., Doyle, M. A., et al. (2020). Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei. BMC Cancer, 20(1), 369.

Article  CAS  Google Scholar 

Su, J., Jin, G. X., Votanopoulos, K. I., et al. (2020). Prognostic molecular classification of appendiceal mucinous neoplasms treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Annals of Surgical Oncology, 27(5), 1439–1447.

Article  Google Scholar 

Tsai, J. H., Yang, C. Y., Yuan, R. H., et al. (2019). Correlation of molecular and morphological features of appendiceal epithelial neoplasms. Histopathology, 75(4), 468–477.

Article  Google Scholar 

LaFramboise, W. A., Pai, R. K., Petrosko, P., et al. (2019). Discrimination of low- and high-grade appendiceal mucinous neoplasms by targeted sequencing of cancer-related variants. Mod Pathol, 32(8), 1197–1209.

Article  CAS  Google Scholar 

Liu, W., Liu, L., Wang, R., et al. (2019). Bevacizumab combined with oxaliplatin/capecitabine in patient with refractory and recurrent mucinous adenocarcinoma of the appendix: A case report. Front Oncol, 9, 55.

Article  CAS  Google Scholar 

Tokunaga, R., Xiu, J., Johnston, C., et al. (2019). Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer. Clinical Cancer Research, 25(10), 3096–3103.

Article  CAS  Google Scholar 

Zhu, X., Salhab, M., Tomaszewicz, K., et al. (2019). Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms. Human Pathology, 85, 260–269.

Article  CAS  Google Scholar 

Ang, C. S., Shen, J. P., Hardy-Abeloos, C. J., et al. (2018). Genomic landscape of appendiceal neoplasms. JCO Precision Oncology, 8(2), 1–18.

Gleeson, E. M., Feldman, R., Mapow, B. L., et al. (2018). Appendix-derived pseudomyxoma peritonei (PMP): Molecular profiling toward treatment of a rare malignancy. American Journal of Clinical Oncology, 41(8), 777–783.

Article  CAS  Google Scholar 

Pengelly, R. J., Rowaiye, B., Pickard, K., et al. (2018). Analysis of mutation and loss of heterozygosity by whole-exome sequencing yields insights into pseudomyxoma peritonei. Journal of Molecular Diagnostics, 20(5), 635–642.

Article  CAS  Google Scholar 

Wen, K. W., Grenert, J. P., Joseph, N. M., et al. (2018). Genomic profile of appendiceal goblet cell carcinoid is distinct compared to appendiceal neuroendocrine tumor and conventional adenocarcinoma. Human Pathology, 77, 166–174.

Article  CAS  Google Scholar 

Ang, C., Stollman, A., Zhu, H., et al. (2017). Clinical benefit from trametinib in a patient with appendiceal adenocarcinoma with a gnas r201h mutation. case rep oncol, 10(2), 548–552.

Article  Google Scholar 

Matson, D. R., Xu, J., Huffman, L., et al. (2017). KRAS and GNAS Co-mutation in metastatic low-grade appendiceal mucinous neoplasm (LAMN) to the ovaries: A practical role for next-generation sequencing. Am J Case Rep, 18, 558–562.

Article  Google Scholar 

Saarinen, L., Nummela, P., Thiel, A., et al. (2017). Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei. PLoS One, 12(4), e0174898.

Article  Google Scholar 

Borazanci, E., Millis, S. Z., Kimbrough, J., et al. (2017). Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis. J Gastrointest Oncol, 8(1), 164–172.

Article